NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 165 filers reported holding NEVRO CORP in Q2 2019. The put-call ratio across all filers is 5.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $4,779,000 | +145.7% | 40,000 | +33.3% | 1.58% | +236.8% |
| Q2 2019 | $1,945,000 | -37.8% | 30,000 | -40.0% | 0.47% | -59.2% |
| Q1 2019 | $3,126,000 | – | 50,000 | – | 1.15% | – |
| Q3 2018 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q2 2018 | $1,278,000 | -57.9% | 16,002 | -54.3% | 0.49% | -65.3% |
| Q1 2018 | $3,033,000 | – | 35,000 | – | 1.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |